Search results
3 German firms considering PHL expansions, PEZA says - BusinessWorld Online
BusinessWorld· 6 hours agoTHE Philippine Economic Zone Authority (PEZA) said three German companies in the automotive, semiconductor, and pharmaceutical industries are planning to expand their Philippine ...
Medical company plans $225M investment, 274 jobs in West Chester Twp.
WCPO Cincinnati· 5 days agoA San Diego-based biomanufacturer has committed to creating 274 new full-time jobs after receiving a tax incentive from the state, and nearly 100 jobs are needed to be filled by this summer ...
Trump or Biden? Either way, US seems poised to preserve heavy tariffs on imports
Wisconsin State Journal· 9 hours agoAs president, Donald Trump imposed a 25% tariff on foreign steel, which hurt Clips & Clamps...
Axios Vitals
Axios· 5 days agoWhy it matters: There's widespread agreement that pharmaceutical companies have gamed the system through tactics like "product hopping," where a drug company makes small changes ...
Nearly $2 million in ARPA seed money sought for workforce development initiative in Athens
Gannett via AOL· 6 days agoThe...Bradley said. The money for the jobs portal initiative would include contracting with a job...
AstraZeneca to build $1.5bn ADCs facility in Singapore
Investment Monitor via Yahoo Finance· 7 days agoPharmaceutical giant AstraZeneca has announced plans to invest $1.5bn in a new antibody-drug...
Column: Big Pharma giveaway will increase working families' health costs
The Salem News· 4 days agoSmall business owners are the drivers of the U.S. economy. Our innovation, creativity, and willingness to take risks ensure a steady supply of job creation and economic activity ...
Drug giant Takeda plans more than 640 layoffs in Massachusetts - The Boston Globe
The Boston Globe· 2 days agoTakeda Pharmaceutical, the largest drug maker in Massachusetts by headcount, on Friday confirmed...
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
Zacks· 3 days agoAstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase cost reduction program.
Private Equity Is Bad for Your Health
Bloomberg· 4 days agoLisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry. Previously, she was executive editor of...
